Heart Rhythm
Volume 6, Issue 7 , Pages 998-999 , July 2009

HCM, SCD, ICD: An alphabet of risks, gaps, and patient counseling

  • Steve R. Ommen, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Steve R. Ommen, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905

References 

  1. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385–e484
  2. Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412
  3. Nishimura RA, Ommen SR. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?. JAMA. 2007;298:452–454
  4. Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice. Heart. 2008;94:1269–1275
  5. Maron B, Haas TS, Shannon KM, Almquist AK, Hodges JS. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm. 2009;6:993–997

PII: S1547-5271(09)00429-9

doi: 10.1016/j.hrthm.2009.04.014

Heart Rhythm
Volume 6, Issue 7 , Pages 998-999 , July 2009

Article Tools